Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,General Pharmacology, Toxicology and Pharmaceutics,Toxicology,Pathology and Forensic Medicine
Reference64 articles.
1. Yang, B. & Papoian, T. Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and future. J Appl Toxicol
38, 790–800 (2018).
2. Okwuosa, T. M. & Barac, A. Burgeoning cardio-oncology programs: challenges and opportunities for early career cardiologists/faculty directors. J Am Coll Cardiol
66, 1193–1197 (2015).
3. Vaidya, T., Kamta, J., Chaar, M., Ande, A. & Ait-Oudhia, S. Systems pharmacological analysis of mitochondrial cardiotoxicity induced by selected tyrosine kinase inhibitors. J Pharmacokinet Pharmacodyn 2018 Feb 14. doi: 10.1007/s10928-018-9578-9. [Epub ahead of print]
4. Jain, D., Russell, R. R., Schwartz, R. G., Panjrath, G. S. & Aronow, W. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions. Curr Cardiol Rep
19, 36 (2017).
5. Force, T. & Kolaja, K. L. Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov
10, 111–216 (2011).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献